Adaptive, a company dedicated to transforming capital markets through technology, has announced raising a substantial $19,000,000 in funding. Founded in 2012, Adaptive specializes in solving intricate business problems, utilizing cutting-edge technology, and fostering collaborative partnerships with clients. This recent funding will further bolster their mission of designing and delivering advanced trading technology solutions to capital and commodity market participants. With a focus on providing clients with a competitive edge through innovative tech accelerators, Adaptive aims to empower businesses to thrive in the ever-evolving market landscape. The company's dedication to delivering tailored solutions that drive real business value has positioned them as a key player in the industry. This funding injection will enable Adaptive to continue reducing time-to-market for their clients, allowing them to seize opportunities swiftly and maintain a strategic advantage over their competitors.
Empowering Capital Markets: Adaptive Secures $19M in Series A Funding
Recently funded · $19.0M Series aTechnology/Trading
Get the full Adaptive company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
$1.5M Pre-seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
